BeOne Medicines (ONC) Assets Average (2016 - 2026)

BeOne Medicines (ONC) has 11 years of Assets Average data on file, last reported at $8.4 billion in Q1 2026.

• Quarterly Assets Average rose 42.34% year-over-year to $8.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.4 billion (up 42.34% YoY) and the FY2025 annual result came in at $7.1 billion, up 20.32% from the prior year.
• Assets Average climbed to $8.4 billion in Q1 2026 per ONC's latest filing, from $7.9 billion in the prior quarter.
• Across five years, Assets Average topped out at $8.4 billion in Q1 2026 and bottomed at $5.6 billion in Q3 2023.
• The 5-year median for Assets Average is $5.9 billion (2025), against an average of $6.5 billion.
• The widest annual swing landed in 2022, when Assets Average jumped 44.96%; it then plunged 30.92% in 2023.
• Tracing ONC's Assets Average over 5 years: stood at $6.1 billion in 2022, then slipped by 7.18% to $5.7 billion in 2023, then grew by 3.72% to $5.9 billion in 2024, then jumped by 34.63% to $7.9 billion in 2025, then grew by 5.82% to $8.4 billion in 2026.
• Per Business Quant, the three latest ONC Assets Average figures stand at $8.4 billion (Q1 2026), $7.9 billion (Q4 2025), and $7.0 billion (Q3 2025).

Peer Comparison